top of page

Thank you - Alzheimer’s Research UK!

Aries Biotech extends gratitude to the Alzheimer’s Research UK team, for inviting Dr. Angela Boutte, the founder of Aries Biotech, as a contributing reviewer and panelist. Through partnerships with the Alzheimer’s Society, National Institute for Health Research (NIHR), and memory clinics across the UK, ARUK funds community based, prospective studies that determine how blood-based biomarkers can improve the AD diagnosis. Aries Biotech supports groundbreaking biomarker research and community-based medicine that address disparities in diagnostic service access.


Additional information about ARUK may be found at


Aries Biotech is a neurological disease and dementia biomarker consulting company that provides guidance, data interpretation, document review, and investor support. To learn more, visit Aries Biotech at https://www.ariesbiotechnologies.com.


Check out our community interest survey at https://forms.wix.com/f/7075978737291886849





10 views0 comments

Recent Posts

See All

Dr. Boutte Joins PRECISE-TBI Biomarker Working Group

Dr. Boutte Joins PRECISE-TBI Biomarker Working Group Aries Biotech extends gratitude to the PRECISE-TBI team, for inviting Dr. Angela Boutte, the founder of Aries Biotech, to participate in the precli

Dr. Boutte of Aries Biotech Consults for BBCETC

Dr. Boutte of Aries Biotech is honored to serve as a consultant for BBC Entrepreneurial Training & Consulting (BBCetc).  The BBCetc (https://bbcetc.com/) is nationally recognized for successfully help

Thank you, UCLA!

Aries Biotech extends gratitude to the UCLA Alumni Association for inviting Dr. Angela Boutte, the founder of Aries Biotech, to serve as an undergraduate mentor. Aries Biotech supports diversity and

bottom of page